U.S. flag

An official website of the United States government

NM_002834.5(PTPN11):c.235C>A (p.Gln79Lys) AND Noonan syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 28, 2013
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000037640.5

Allele description [Variation Report for NM_002834.5(PTPN11):c.235C>A (p.Gln79Lys)]

NM_002834.5(PTPN11):c.235C>A (p.Gln79Lys)

Gene:
PTPN11:protein tyrosine phosphatase non-receptor type 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.13
Genomic location:
Preferred name:
NM_002834.5(PTPN11):c.235C>A (p.Gln79Lys)
HGVS:
  • NC_000012.12:g.112450415C>A
  • NG_007459.1:g.36684C>A
  • NM_001330437.2:c.235C>A
  • NM_001374625.1:c.232C>A
  • NM_002834.5:c.235C>AMANE SELECT
  • NM_080601.3:c.235C>A
  • NP_001317366.1:p.Gln79Lys
  • NP_001361554.1:p.Gln78Lys
  • NP_002825.3:p.Gln79Lys
  • NP_542168.1:p.Gln79Lys
  • LRG_614t1:c.235C>A
  • LRG_614:g.36684C>A
  • NC_000012.11:g.112888219C>A
  • NM_002834.3:c.235C>A
  • c.235C>A
Protein change:
Q78K
Links:
dbSNP: rs397516803
NCBI 1000 Genomes Browser:
rs397516803
Molecular consequence:
  • NM_001330437.2:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374625.1:c.232C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002834.5:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080601.3:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Noonan syndrome (NS)
Synonyms:
Noonan's syndrome; Pseudo-Turner syndrome
Identifiers:
MONDO: MONDO:0018997; MeSH: D009634; MedGen: C0028326; OMIM: PS163950

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000061302Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely pathogenic
(Jan 28, 2013)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided31not providednot providednot providedclinical testing

Citations

PubMed

Case report: Noonan syndrome with multiple giant cell lesions and review of the literature.

Karbach J, Coerdt W, Wagner W, Bartsch O.

Am J Med Genet A. 2012 Sep;158A(9):2283-9. doi: 10.1002/ajmg.a.35493. Epub 2012 Jul 27. Review.

PubMed [citation]
PMID:
22848035

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.

Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt Iv, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD.

Am J Hum Genet. 2006 Feb;78(2):279-90. Epub 2005 Dec 7.

PubMed [citation]
PMID:
16358218
PMCID:
PMC1380235
See all PubMed Citations (4)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000061302.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (4)

Description

The Gln79Lys variant in PTPN11 has been identified by our laboratory in three af fected individuals in from a family with clinical features of Noonan syndrome. W hile this variant has not been reported in the literature, two different amino a cid changes at this position have been reported and identified by our laboratory in many individuals with clinical features of Noonan syndrome (Gln79Arg, Gln79P ro; Karbach 2011, Sarkozy 2003, Tartaglia 2006). At least two of these cases occ urred de novo (Sarkozy 2003). Computational analyses (biochemical amino acid pro perties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong sup port for or against an impact to the protein. In summary, this variant is likely pathogenic based on the presence of other pathogenic variants at this position and the segregation of this variant in family members, though additional studies are required to fully establish its clinical significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided3not provided1not provided

Last Updated: Sep 29, 2024